Filing Flows › GE HealthCare Technologies (GEHC) › R&D spending
GE HealthCare Technologies (GEHC) R&D spending by quarter
GE HealthCare Technologies' R&D spending was $320M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026. Over the last 7 quarters it ranged from $292M (Q3 2025) to $345M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $320M | -0.9% | +10% |
| Q2 2026 | $323M | -6% | +7% |
| Q1 2026 | $345M | +7% | +0.3% |
| Q4 2025 | $323M | +11% | — |
| Q3 2025 | $292M | -3% | — |
| Q2 2025 | $302M | -12% | — |
| Q1 2025 | $344M | — | — |
Q3 2026 at a glance
GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart follows the revenue to costs, profit and cash.
Questions
What is GE HealthCare Technologies' R&D spending?
GE HealthCare Technologies' R&D spending was $320M in Q3 2026 (third quarter 2026), -0.9% from Q2 2026.
How has GE HealthCare Technologies' R&D spending changed?
Over the last 7 quarters it ranged from $292M (Q3 2025) to $345M (Q1 2026).
Q3 2026 results → · How GE HealthCare Technologies makes money →